Rare variants of histiocytic tumors: peculiarities of diagnosis and choice of treatment (literature review)

Author:

Valiev T. T.1ORCID,Gurieva O. D.2ORCID,Pavlovskaya A. I.2ORCID

Affiliation:

1. N.N. Blokhin National Medical Research Center of Oncology, Ministry of Health of Russia; I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia (Sechenov University)

2. N.N. Blokhin National Medical Research Center of Oncology, Ministry of Health of Russia

Abstract

Histiocytic tumors are a highly heterogeneous group of diseases, with Langerhans cell histiocytosis occupying the main place among it. Despite the rare frequency of occurrence, long-term analysis of clinical, morpho-immunological and molecular-biological features has allowed the development of effective treatment protocols (especially in the pediatric cohort of patients). In addition to Langerhans cell histiocytosis, the histiocytic tumors group includes rare and casuistic variants, which include histiocytic sarcoma, Langerhans cell sarcoma, indeterminate dendritic cell tumor, interdigitating dendritic cell sarcoma, follicular dendritic cell sarcoma, and fibroblastic reticular cell tumor. The incidence of certain nosological variants is several cases per hundreds of millions of the population. Not surprisingly, the diagnostic criteria for this group of tumors need to be clarified, as do the therapeutic approaches. This review presents current data on rare histiocytic tumors, clinical features as well as morphological and immunobiological characteristics of the tumor substrate. The results of modern surgical and therapeutic treatment approaches are presented.

Publisher

Publishing House ABV Press

Subject

Oncology,Hematology

Reference29 articles.

1. Tang X., Gao J., Ma Z.G. et al. Clinical and prognostic characteristics of 95 cases of Langerhans cell histiocytosis in children: a single-institute experience from 2013 to 2020. Ann Med 2021;53(1):1537–46. DOI: 10.1080/07853890.2021.1966085.

2. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues (Revised 4th edn.). Eds.: S.H. Swerdlow, E. Campo, N.L. Harris et al. Lyon: IARC, 2017. 470 p.

3. Kommalapati A., Tella S.H., Durkin M. et al. Histiocytic sarcoma: a populationbased analysis of incidence, demographic disparities, and long-term outcomes. Blood 2018;131(2):265–8. DOI: 10.1182/blood-2017-10-812495.

4. Doronin V.A., Krivolapov Yu.A., Nechesnyuk A.V., Pivnik A.V. Histiocytic sarcoma. A clinical case and review of the literature. Klinicheskaya onkogematologiya. Fundamental’nye issledovaniya i klinicheskaya praktika = Clinical Oncohematology. Fundamental Research and Clinical Practice 2009;2(2):161–6. (In Russ.)

5. Feldman A.L., Arber D.A., Pittaluga S. et al. Clonally related follicular lymphomas and histiocytic/dendritic cell sarcomas: evidence for transdifferentiation of the follicular lymphoma clone. Blood 2008;111(12):5433–9. DOI: 10.1182/blood-2007-11-124792.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3